AROS is the leading provider of Total Genomic Solutions in Europe. Our service covers all steps from extraction, sample banking, analysis (next generation sequencing, microarrays, LDA cards, PCR etc.) to advanced bioinformatics. The platforms include Affymetrix, Illumina, Agilent, Qiagen, Fluidigm and Applied Biosystems.
The focus is on:
• High Quality build into all steps of processing
(GLP / GCP compliant)
• A flexible set-up to address each customer's specific needs
• A fast turn around time (down to 5 days from sample receipt to
data delivery)
• 24 hours a day/ 7 days a week sample receipt
• Highly experienced staff that has processed more than 100,000
samples and microarrays
• Complete data confidentiality – no claims of rights from
AROS
News
• We wish all a Happy New Year! In our closing 2011 newsletter we are, among others, launching a competitive service offering on Illumina OmniEpxress, potentially including the new HumanExome module, we are informing about new FFPE and plasma/serum extraction services and we are launching a new collaboration with Ingenuity. <more>
• In our October 2011 newsletter you can among others read about single cell gene expression, new miRNA offerings, our new bioinformatics services and exome sequencing. <more>
• AROS has formalized a portfolio of consulting services to enable more customers to take advantage on our knowledge and expertise above and beyond specific projects. Read more about this and our latest NGS and FFPE initiatives in the Q2 2011 Newsletter. <more>
• AROS is offering research institutions and university hospitals attractive outsourcing solutions. Read more about it in our special issue Q4 2010 Newsletter. <more>
• As of October 2010 AROS is offering Next Generation Sequencing services. <more>
• AROS offers Cytogenetic services. Read about how microarrays provide better quality and lower costs in our Q3 2010 Newsletter <more>
• AROS Tip of the Month, July/August 2010 with attractive gene expression offering <more>
• Click here to read the AROS Tip of the Month, June 2010 about Fluidigm <more>
• Please click here to read the Q1 2010 Newsletter <more>
• The Q4 2009 Newsletter is now available <more>
• The Q3 2009 Newsletter is now available <more>
• The Newsletter for Q2 2009 has been send out <more>
• AROS has send out its Newsletter for Q1 2009 <more>
• Illumina service at AROS. AROS is now supplementing its Affymetrix service with services based on the Illumina platform. <more>
• AROS Applied Biotechnology and Stratagene Corporation (NASDAQ:STGN) signs agreement for evaluation and licence of AROS patent portfolio <more>
• AROS offers extractions of microRNA, genomic DNA and total RNA from one single PAXgene Blood RNA Tube - TRI-X <more>